Compared with TET2 which is frequently mutated in hematopoietic malignancies (Huang and Rao, 2014; Jeschke et al., 2016), TET1 mutation is a rare occurrence in cancer (Thomson and Meehan, 2017). This evidence concerns the gene TET2 and cancer.